share_log

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A：并购重组委托声明
美股sec公告 ·  04/23 16:35
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation (SeaStar Medical) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on a date yet to be determined in April 2024. The meeting will address several key proposals, including the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Additionally, stockholders will vote on the approval of an amendment and restatement of the company's 2022 Omnibus Incentive Plan to increase the number of authorized shares. The meeting will also cover the approval of the issuance of 20% or more of the company's outstanding shares of common stock upon exercise of Series A and Series B Warrants, in compliance with Nasdaq Listing Rule 5635(d). Eric Schlorff, Director and CEO, has urged stockholders to vote promptly, highlighting the importance of their votes being represented. The meeting will be accessible online via www.proxydocs.com/ICU, where stockholders can enter their control number to attend and vote.
SeaStar Medical Holding Corporation (SeaStar Medical) has announced the upcoming 2024 Annual Meeting of Stockholders, scheduled to be held virtually on a date yet to be determined in April 2024. The meeting will address several key proposals, including the ratification of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2024. Additionally, stockholders will vote on the approval of an amendment and restatement of the company's 2022 Omnibus Incentive Plan to increase the number of authorized shares. The meeting will also cover the approval of the issuance of 20% or more of the company's outstanding shares of common stock upon exercise of Series A and Series B Warrants, in compliance with Nasdaq Listing Rule 5635(d). Eric Schlorff, Director and CEO, has urged stockholders to vote promptly, highlighting the importance of their votes being represented. The meeting will be accessible online via www.proxydocs.com/ICU, where stockholders can enter their control number to attend and vote.
海星医疗控股公司（SeaStar Medical）宣布即将举行的2024年年度股东大会，该会议计划以虚拟方式举行，日期尚未在2024年4月确定。会议将讨论几项关键提案，包括批准Withumsmith+Brown, PC 作为截至2024年12月31日的财政年度的独立注册会计师事务所。此外，股东将投票批准公司2022年综合激励计划的修正案和重述，以增加授权股票的数量。会议还将涵盖根据纳斯达克上市规则5635（d），批准在行使A系列和B系列认股权证时发行公司20％或以上的已发行普通股。董事兼首席执行官埃里克·施洛夫（Eric Schlorff）敦促股东迅速投票，强调了代表他们的选票的重要性。该会议将通过www.proxydocs.com/ICU在线访问，股东可以在其中输入控制号码参加和投票。
海星医疗控股公司（SeaStar Medical）宣布即将举行的2024年年度股东大会，该会议计划以虚拟方式举行，日期尚未在2024年4月确定。会议将讨论几项关键提案，包括批准Withumsmith+Brown, PC 作为截至2024年12月31日的财政年度的独立注册会计师事务所。此外，股东将投票批准公司2022年综合激励计划的修正案和重述，以增加授权股票的数量。会议还将涵盖根据纳斯达克上市规则5635（d），批准在行使A系列和B系列认股权证时发行公司20％或以上的已发行普通股。董事兼首席执行官埃里克·施洛夫（Eric Schlorff）敦促股东迅速投票，强调了代表他们的选票的重要性。该会议将通过www.proxydocs.com/ICU在线访问，股东可以在其中输入控制号码参加和投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息